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A B S T R A C T 
Acute cholecystitis in severely cardiopathic patients after major cardiac surgery represents a challenge for 
surgeons. Treatment with cholecystostomy, may offer a chance to these patients, however there is still a 
number of controversial issues on the topic: performance surgical techniques (transhepatic or 
transpapillary), optimal duration and timing of drain removal, the need for further tests before removal as 
well as the timing for definitive surgery. We therefore deemed it important to share our experience of a 
multidisciplinary approach for the definitive treatment of this patient with severe heart disease. A 
percutaneous cholecystostomy was the chosen strategy for a 58-year-old cardiopathic patient who had 
undergone surgery for hip replacement and had developed acute calculous cholecystitis a few days after 
surgery. Two weeks after discharge, a cholangiography through the cholecystostomy and an MRI 
cholangiopancreatography revealed the presence of stones in the cystic duct and in the ductus choledochus. 
The definitive treatment was decided after consulting with a multidisciplinary team. The choice was to 
perform an open cholecystectomy with simultaneous removal of the cholecystostomy, endoscopic removal 
of stones and sphincterotomy of the Oddi papilla. Currently, the patient is healthy and his heart function 
satisfactory. Although early cholecystectomy is the recommended choice for acute cholecystitis, a patient 
with severe co-morbidities may benefit from a bridging therapy before definitive surgery and a 
multidisciplinary approach can provide a safer solution. 
 




In case of patients unfit for surgery (due to co-morbidities) the Tokio 
Guidelines (TG) 2018 recommend the use of percutaneous 
cholecystostomy (PC) both in grade II and III cholecystitis because this 
method allows to convert a septic cholecystitis into a non-septic situation 
with a reduction of inflammation and improvement in clinical condition 
[1, 2]. However the WSES guidelines reported lack of higher level 
evidence (LoE 4, GoR C) on this topic [3, 4]. In general, an analysis of 
the relevant literature confirmed this lack and the need for randomized 
clinical trials. There are still controversial issues regarding 
cholecystostomy: the techniques used to perform it (transhepatich or 
transpapillary), optimal duration and removal time, indications for 
further examinations prior to removal and finally, the optimal timing of 
definitive surgery.  
 
In this paper, we report the case of a patient presenting with acute 
calculous cholecystitis following recent hip replacement, who had 
undergone several complex cardiac surgical procedures for myocardial 
infarction with interventricular septal rupture 18 months earlier. We 
deemed it important to share our experience in this case of acute 
cholecystitis in a severe cardiopathic patient, providing an overview of 
the literature on the treatment with PC insertion as a bridge therapy as 





A 58-year-old man with cardiopathy, admitted to the Internal and Post-
surgical Medicine Unit of our hospital, presented with calcolous 
cholecystitis during the postoperative course following the prosthetic 
replacement of the femoral head under spinal anaesthesia performed in 
June 2019. The calculous cholecystitis was confirmed by ultrasound 
examination and CT scan, that showed a fluid collection around the 
gallbladder with delaminated walls and presence of stones. Leukocytosis 
and abdominal pain were also present. The patient’s home therapy 
included: oral assumption of aspirin, bisoprolol, furosemide, ivabradine, 
metolazone, potassium canrenoate after the emergency cardiac surgery 
for acute post-myocardial infarction rupture in the posterior portion of 
the interventricular septum (IVSR) he had undergone about 18 months 
earlier. For the surgical repair, a bovine pericardial patch was used 
(“infarction exclusion technique”) through the left ventricular posterior 
wall and a concomitant coronary artery bypass graft (CABG) with the 
left internal mammary artery anastomosed sequentially to the left 
anterior descending artery and the first diagonal branch.  
 
The postoperative cardiac echocolordoppler showed a significant post-
operative residual left-to-right shunt and therefore a new elective 
treatment was planned. A month after surgery, a percutaneous attempt 
was carried out (with Amplatzer VSD Muscular Occluder n. 18mm) to 
close the residual IVSR but it was unsuccessful, and a redo surgery was 
needed. In this instance, after the implantation of an Intra-Aortic Balloon 
Pump (IABP), the septum was repaired through the tricuspid valve. A 
mitral valve annuloplasty (with St Jude ring n. 26mm) and tricuspid 
valve annuloplasty (by the Kay-technique) were also required. The 
postoperative course was uneventful except for the onset of a marked 
bradycardia that required pacemaker implantation. At the time of the 
hospital discharge, the patient was symptomless and in a good and stable 
hemodynamic status. The cardiac ultrasound examination showed a 
residual mild left-to-right shunt, a moderate right ventricular dysfunction 
and a left ventricular ejection fraction of 35%. Follow-up outpatient 
checkups confirmed the stability of the patient’s hemodynamic and 
clinical status. 
 
At the time of acute cholecystitis, due to the high risk cardiac condition, 
a bridging procedure with placement of a percutaneous cholecystostomy 
(PC) was the chosen strategy. PC was performed transhepatically under 
local anaesthesia by our Interventional Radiologists Team. Two weeks 
after discharge, a cholangiography through the cholecystostomy 
revealed the presence of stones in the cystic duct and in the ductus 
choledochus, confirmed by MRI cholangiopancreatography. The 
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definitive treatment was decided after consulting with a 
multidisciplinary team composed of cardiac surgeons, cardiologists, 
anaesthesiologists and endoscopists. 
 
His cardiac condition was checked once again before surgery, revealing 
31% ejection fraction (EF), slight pulmonary hypertension, minimal 
tricuspid valve insufficiency. The intraoperative phase was managed 
using advanced hemodynamic and anaesthesia monitoring that included 
pulse contour analysis to determine the continuous cardiac output 
(MostCareUP, Vygon, Caen, France), trans-esophageal 
echocardiography, and depth of anaesthesia monitoring (Sedline®, 
Masimo, Irvine, CA, USA). An open cholecystectomy was performed 
with the simultaneous removal of the cholecystostomy tube, endoscopic 
extraction of stones and sphincterotomy of the Oddi papilla. After 
surgery, the patient was transferred to the general Intensive Care Unit 
and then to the Cardiac Surgery Unit from which he was discharged in 
satisfactory health condition on the tenth postoperative day. He is 
presently healthy and in good shape. 
 
Discussion and Conclusion 
 
An initial literature search on the subject ‘Cholecystostomy’ and 
“Cholecystitis surgical treatment” produced several observational 
studies, a systematic review, a propensity score analysis in elderly and a 
Cochrane Systematic review [5-30]. The selection criteria used for the 
observational studies, but also results and often the conclusions reached 
by various Authors were found to be largely non-homogeneous. The 
systematic review stated that PC was performed after failure of medical 
treatment and was associated to unacceptably high rates of complications 
and mortality [28]. The propensity score study, that showed a lower rate 
of definitive cholecystectomy and a higher mortality and readmission 
rate, concluded that a refinement to the Tokio guidelines was needed on 
this topic [29]. The Cochrane Systematic Review confirmed a lack of 
clear indications for the use of PC in the clinical management of high 
risk surgical patients with cholecystitis and underlined the need of 
randomized clinical trials [30]. 
 
Regarding cholecystostomy placement techniques, although according 
to TG2018 transhepatic percutaneous cholecystostomy remains the 
recommendation, it is also worth examining a systematic review and a 
propensity score paper found in the literature [1, 31-34]. The first 
compared EUS-guided gallbladder drainage (EUS-GBD) vs endoscopic 
transpapillary gallbladder drainage (ET-GBD), showing that EUS-GBD 
was the better choice because of higher rate of technical and clinical 
success and lower rate of recurrent cholecystitis [33]. The second paper 
compared percutaneous and endoscopic gallbladder drainage [34]. 
Results showed that there were no significant differences between the 
two techniques in clinical efficacy and complication rate. 
 
Also the optimal duration of PC drainage, as reported in a paper by 
Hasbahceci et al. is still a controversial issue [8]. The suggested time is 
considered to be three to six weeks, with an average of one month, but 
Morse et al. recommended that the PC tube should remain in place in 
critically ill patients until cholecystectomy (Table 1) [11]. The same was 
suggested by Wang et al. [35]. However, other studies reported adverse 
events, one of them indicating that a drainage duration longer than two 
weeks may be associated with increased recurrence rate [6]. Other 
policies have been catheter removal after confirmation of the patency of 
the cystic duct [33]. Discharge with the PC tube in place until 
cholecystectomy has also been reported [6]. So far, no definitive 
conclusion has been drawn on timing, although catheter removal can 
generally be performed after temporary clamping [10]. Some Authors 
left the PC tube in place as a bridge procedure and performed early 
surgery after a mean of 9.68 ± 6.45 days [11]. However, further studies 
are needed to clarify the timing of PC tube removal before definitive 
surgery. Furthermore, recurrence after catheter removal is an important 
issue in patients not undergoing surgical treatment [6, 8, 11]. 
 
Table 1: Articles (2010-2020) reporting a time interval between cholecystostomy and cholecystectomy. 
Author Title Journal Timing for cholecystostomy removal an 
definitive cholecystectomy 
De Geus T et al. [47] 
2020 
Outcomes of patients treated with upfront 
cholecystostomy for severe acute choelcystytis. 
Surg Laparosc Endosc percutan 
Tech 2020;30:79-84 
No timing definition  reported 
Masrani A et al. [17] 
2020 
Management algorithm of acute cholecystitis after 
percutaneous cholecystostomy catheter placement 
based on outcomes from 377 patients 
Abdominal radiology 
20205:1193-1197 
Cholangiography after two weeks , no 
definite timing for catheter removal and 
delayed cholecystectomy 
Alotaibi A et al. [48] 
2019 
Is cholecystostomy e real bridge for cholecystectomy 
ub acute cholecystitis. A retrospective cohort study  
Saudi J Health Sci 2019;8:157-
61 
No timing definition  reported 
Aroori S et al.[5] 
2019 
Percutanous cholecystostomy for severe acute 
cholecystitis: a useful procedure in high-risk patients 
for surgery.   
Scandinavian Journal of Surgery 
2019, Vol. 108(2) 124 –129. 
DOI: 
10.1177/1457496918798209 
Removal of the cholecystostomy after 6 
weeks and concurrent cholecistectomy 
Pal I et al. [21] 
2018 
Role of percutaneous cholecystostomy tube placement 
in the management of acute calculus cholecystitis in 
high risk patients 
JCPSP 2018;28 (5):386-389 6-8 weeks after cholecystostomy placement 
Kim D et al. [15] 
2018 
Expanding role of percutaneous cholecystostomy and 
interventional radiology for the management of acute 
cholecystitis: An analisys of 144 patients 
Diagnost Intervent Imaging 
2018;99:15-21 
No timing definition reported 
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Hasbahceci M et al. 
[8] 2018 
The impact of a percutaneous cholecystostomy 
catheter in situ until the time of cholecystectomy on 
the development of recurrent acute cholecystitis: a 
historical cohort study 
Rev Esp Enferm Dig 
2018:110(10):629-633. DOI: 
10.17235/reed.2018.5644/2018 
6-8 weeks after cholecystostomy placement 
(3 groups:1)PC no further treatment,2) 
removal of the PC and subsequent 
cholecystectomy,3) PC left in situ until 
removal at the beginning of surgery) 
Dai Y et al. [49] 
2017 
Current status of percutaneous cholecystostomy for 
the management of cholecystitis 
Dig Div Interv 2017;1:22-27 No timing definition reported 
Zeren S et al. [50] 
2017 
Bridge treatment for early cholecystectomy in geriatric 
patients with acute cholecystitis:percutaneous 
cholecystostomy 
Ulus Trauma Acil Cerrahi Derg 
2017;23 (6):501-505 
No timing definition reported 
Bala M et al. [51] 
2016 
Percutaneous cholecystostomy is safe and effective 
option for acute cholecystitis in select group of high-
risk patients 
Eur J Trauma Emerg Surg 
2016;42:761-766 
No timing definition reported 
Popowicz A et al. 
[12] 
2016 
Cholecystostomy as Bridge to Surgery and as 
Definitive Treatment or Acute Cholecystectomy in 
Patients with Acute Cholecystitis 
Gastroenterology Research and 




No timing definition reported 
Suzuki K et al. [20] 
2015 
Tube cholecystostomy before cholecystectomy for the 
treatment of acute cholecystitis 
JSLS2015(19)1 
DOI:10.4293/JSLS.2014.00200 
No timing definition reported 
Jung W et al. [16] 
2015 
Timing of cholecystectomy after percutaneous 
cholecistostomy for acute cholecystitis 
Korean J Gastroenterol 
2015;66:209-214 
No timing definition reported 
(patients diveded in two group: group1 
mild disease had surgery within 10 days. 
Group 2 moderate disease had surgery after 
10 days 
Jang WS et al. [10] 
2015 
Outcome of conservative percutaneous 
cholecystostomy in high-risk patients with acute 
cholecystitis and risk factors leading to surgery 
Surg Endosc 2015;29:2359-64. 
DOI: 10.1007/ s00464-014-
3961-4 11. 
Laparoscopic cholecystectomy within 7 
days after PC or more than 7 days after PC 
placement  
Mizrahi I et al. [52] 
2015 
Perioperative outcomes of delayed laparoscopic 
cholecystectomy for acute with and without 
percutaneous cholecystostomy  
Surgery 2015; 158:728-35. 6-8 weeks after PC placement 
Sanjay P et al. [19] 
2013 
Clinical outcomes of a percutaneous cholecystectomy 
for acute cholecystitis:a multicentre analysis 
HPB 2013;15:511-516 4-6-weeks after PC placement 
Hsieh YC et al. [6] 
2012 
Outcome after percutaneous cholecystostomy for 
acute cholecystitis: a single-center experience 
J Gastrointest Surg 
2012;16:1860-8. DOI: 
10.1007/s11605-012-1965-8 
8-10days from PC insertion after 
symtomatology resolution 
Morse BC et al. [11] 
2010 
Management of acute cholecystitis in critically ill 
patients: contemporary role for cholecystostomy and 
subsequent cholecystectomy 
Am Surg 2010;76:708-12 small patient population. In critically ill 
patients, cholecystostomy tubes should 
remain in place until the patient is  suitable 
to undergo cholecystectomy. Removal of 
the cholecystostomy tube without 
subsequent cholecystectomy is associated 
with a high incidence of recurrent 
cholecystitis and devastating consequences. 
Chok KS et al. [18] 
2010 
Results of percutaneous transhepatic cholecystostomy 
for high surgical risk patients  with acute cholecystitis 
ANZ J Surg 2010;80:280-3.  
doi:10.1111/j.1445-
2197.2009.05105.x 
No timing definition reported 
Koebrugge B et al. 
[9] 2010 
Percutaneous cholecystostomy in critically ill 
patientswith cholecystitis: a sale option 
Dig Surg 27:417-421, 2010 No timing definition reported 
 
Both the 2016 WSES guidelines on acute cholecystitis, and in the 2017 
WSES and SICG guidelines on acute calculous cholecystitis in the 
elderly, mentioned the CHOCOLATE study, an ongoing multicentre 
randomized clinical trials on laparoscopic cholecystectomy versus 
percutaneous catheter drainage for acute cholecystitis in high risk 
patients [3, 4, 36, 37]. In 2018 Loozen et al. reported that the definitive 
results of the CHOCOLATE study stated that while the mortality rate, 
one of the primary endpoints of the study, did not differ significantly 
between the two groups, (percutaneous cholecystostomy vs early 
cholecystectomy (P=0.27), differences were significant in the other 
primary endpoint, i.e. the occurrence of major complications, in favour 
of early cholecystectomy (risk ratio 0.19, 95% confidence interval 0.10 
to 0.37, P=0,001) [37]. The conclusion was that among high risk patients 
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with acute cholecystitis, cholecystectomy was the preferred treatment 
over percutaneous cholecystostomy. 
 
However, the rate of recurrent gallstone related symptoms could have 
been lower if all the patients with drainage had undergone definitive 
elective cholecystectomy. The CHOCOLATE study did not explore the 
possibility of cholecystectomy after PC placement, due to the fact that 
PC by itself is considered the best definitive treatment for avoiding 
surgical complications [18, 37-40]. To the best of our knowledge, no 
studies are presently available on clinical, biochemical or radiological 
predictors for failure of percutaneous catheter drainage in acute 
cholecystitis. 
 
As to the high risk assessment of individual patients some authors report 
that in patients with an ASA score grade III and IV, PC is a minimally 
invasive treatment with a low complication rate for patients with ACC 
[5, 6, 10]. In particular, in a retrospective study Aroori et al. examined 
53 patients who had undergone PC [5]. Patients fit enough for surgery 
had the PC removed at the time of surgery and a definitive 
cholecystectomy was performed after 6 weeks. Despite the fact that, 
based on the risk assessment over 50% of the patients were ASA IV and 
V, the majority survived and underwent the PC procedure. The 
associated presence of common bile duct stone (Choledocholithiasis) at 
presentation, has been reported to occur in 10-20% in case series of 
cholelithiasis, with a lower incidence during ACC ranging from 5-15% 
of the patients [35, 41, 42].  
 
The American Society of Gastrointestinal Endoscopy and the Society of 
American Gastrointestinal Endoscopic Surgeons of risk stratification of 
common bile duct stones (CBDS) defined three different classes: low 
risk (<10%), moderate (10 to 50%) and high risk (> 50%), (ASGE 2010) 
[43, 44]. Patients with a low risk of CBDS should be operated upon 
without further investigation. Patients with moderate risk should 
undergo a second level examination, i.e., preoperative endoscopic 
ultrasound (EUS) or preoperative magnetic resonance 
cholangiopancreatography (MRCP) or intraoperative laparoscopic 
ultrasound or laparoscopic cholangiography. Depending on the different 
clinical conditions assessed, patients shall undergo stone removal prior, 
during or after surgery. Patients at high risk for CBDS should directly 
proceed to preoperative diagnostic and therapeutic ERCP. With regard 
to preoperative imaging techniques, Magnetic Resonance 
Cholangiopancreatography and Endoscopic Ultrasound are the 
diagnostic procedures of choice.  
 
Intraoperative cholangiography is an invasive procedure with potential 
severe complications. Positive findings on intraoperative 
cholangiography lead to intraoperative management of CBDS with 
prolonged operative time. In this case we utilized ERCP plus 
sphincterotomy as a combination of intraoperative procedure with the 
rendezvous technique [1, 11, 25]. Its morbidity includes pancreatitis, 
cholangitis, hemorrhage, duodenal perforation or allergy to contrast. 
However, while intraoperative cholangiography significantly increases 
the length of surgery intraoperative ERCP plus sphincterotomy reduce 
risks for post-ERCP pancreatitis [1, 3]. Both the procedures require a 




This case presented the following critical points: 
i. The choice of a multidisciplinary approach to select the best 
management in difficult clinical cases.  
ii. The evaluation of the patient’s heart conditions related to a 
reduced EF, a persistent ventricular septal defect due to previous 
myocardial infarction with ventricular septal rupture that had 
required numerous surgical repairs and pacemaker placement.  
iii. The choice of PC for first line treatment as a bridge procedure to 
manage the acute situation before definitive treatment. 
iv. The choice of a delayed open cholecystectomy with 
cholecystostomy tube removal at the time of surgery associated 
to a rendezvous for the removal of biliary stones from the 
Common Biliary Duct (CBD) and simultaneous endoscopic 
sphincterotomy for Oddi dysfunction. 
 
The choice at presentation for acute cholecystitis of a bridging procedure 
was decided autonomously by the surgeon on call as the best solution to 
solve the acute condition before definitive surgery. This choice is 
supported by several studies suggesting that PC followed by 
laparoscopic cholecystectomy is a suitable management for patients with 
ACC who are deemed unfit for emergency surgery [8, 12, 45]. In a paper 
of 2016, Popowicz et al., reviewed the medical reports of seven hospitals 
with 799 pts. admitted in 2003 and 850 in 2008 [12]. Multivariate 
regression analysis was performed with adjustments for age, gender, 
degree of cholecystitis and Charlson comorbidity index [46]. Notably, 
although patients treated with cholecystectomy as a bridge to elective 
surgery, were older with a predominance of females, the complications 
reported in the “bridge to surgery” group were entirely confined to the 
subsequent final gallbladder operation, confirming the Authors’ 
conclusion that PC is a safe option in high risk patients with ACC. The 
only negative finding was the longer hospital stay in the PC group. 
 
The multidisciplinary teamwork collaboration enabled the sharing of 
information about the patient’s health, from the initial myocardial 
infarction to the required cardiac surgical procedures, up to the removal 
of the gallbladder. This allowed to find a definitive cure and eliminate a 
potential infection starter in a severe cardiopathic patient. The strategic 
adoption of a step by step procedure with PC as bridging therapy before 
definitive cholecystectomy supported by medical and surgical teamwork 
from different specialties has proven to be a valuable approach in 
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